Zenas BioPharma, Inc. Common Stock (ZBIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.90B
Last updated: Nov 17, 2026 at 11:06 AM ET
Zenas BioPharma, Inc. Common Stock (ZBIO) Earnings: Report Dates and Results
Zenas BioPharma, Inc. Common Stock (ZBIO) is expected to report earnings on Mar 15, 2027. In the quarter ended Sep 30, 2026, Zenas BioPharma, Inc. Common Stock reported EPS of -$1.65, below the -$1.20 estimate. It beat the EPS estimate in 2 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ZBIO has an expected report date of Mar 15, 2027.
Earnings History
Of the 10 quarters below that had an estimate, ZBIO beat 3 and missed 7. The widest gap in the table came in the quarter ended Jun 30, 2024, when EPS landed 125.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$1.65 | -$1.20 | N/A | -37.50% | Miss | N/A | 2 | 1 up, 1 down | Nov 5, 2026 | $10.00M |
| Jun 30, 2026 | -$1.77 | -$0.89 | -$1.46 - -$0.05 | -98.88% | Miss | N/A | 2 | N/A | Aug 12, 2026 | $1.00M |
| Mar 31, 2026 | -$1.46 | -$1.54 | -$1.54 - -$1.54 | +5.19% | Beat | N/A | 1 | 0 up, 0 down | May 13, 2026 | N/A |
| Dec 31, 2025 | -$1.39 | -$1.19 | N/A | -16.81% | Miss | N/A | 1 | 0 up, 1 down | Mar 16, 2026 | $10.00M |
| Sep 30, 2025 | -$1.22 | -$0.85 | -$1.21 - -$0.21 | -43.53% | Miss | N/A | 3 | 0 up, 1 down | Nov 12, 2025 | N/A |
| Jun 30, 2025 | -$1.25 | -$1.06 | N/A | -17.92% | Miss | N/A | 1 | 1 up, 0 down | Aug 12, 2025 | N/A |
| Mar 31, 2025 | -$0.80 | -$1.15 | N/A | +30.43% | Beat | N/A | N/A | N/A | May 15, 2025 | $10.00M |
| Dec 31, 2024 | -$1.26 | -$1.02 | N/A | -23.69% | Miss | N/A | N/A | N/A | Mar 25, 2025 | $5.00M |
| Sep 30, 2024 | -$5.02 | -$9.30 | N/A | +46.02% | Beat | N/A | N/A | N/A | Nov 12, 2024 | N/A |
| Jun 30, 2024 | -$2.79 | -$1.24 | N/A | -125.00% | Miss | N/A | N/A | N/A | Aug 22, 2024 | N/A |
Annual EPS
| Fiscal year ended | EPS | Change |
|---|---|---|
| Sep 30, 2026 | -$4.88 | N/A |
| Jun 30, 2026 | -$3.23 | N/A |
| Dec 31, 2025 | -$4.66 | N/A |
| Dec 31, 2024 | -$9.07 | N/A |
Frequently Asked Questions About ZBIO
When is Zenas BioPharma, Inc. Common Stock's next earnings date?
Zenas BioPharma, Inc. Common Stock's next earnings report is expected for Mar 15, 2027.
Did ZBIO beat earnings estimates last quarter?
No. Zenas BioPharma, Inc. Common Stock reported EPS of -$1.65 for the quarter ended Sep 30, 2026, below the -$1.20 estimate by 37.50%.
What EPS do analysts expect from ZBIO next quarter?
The consensus EPS estimate for Zenas BioPharma, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$1.34 from 8 analysts, with estimates from -$1.34 to -$1.28.
How often does ZBIO beat earnings estimates?
Zenas BioPharma, Inc. Common Stock beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -25.34%.
ZBIO pages: Overview, Earnings, Forecast, Financials, Competitors